144 related articles for article (PubMed ID: 14688335)
1. Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II-dependent mechanism.
Murray JC; Symonds P; Ward W; Huggins M; Tiga A; Rice K; Heng YM; Todd I; Robins RA
J Immunol; 2004 Jan; 172(1):274-81. PubMed ID: 14688335
[TBL] [Abstract][Full Text] [Related]
2. Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosis.
Murray JC; Heng YM; Symonds P; Rice K; Ward W; Huggins M; Todd I; Robins RA
J Leukoc Biol; 2004 May; 75(5):772-6. PubMed ID: 14982944
[TBL] [Abstract][Full Text] [Related]
3. Cell-surface associated p43/endothelial-monocyte-activating-polypeptide-II in hepatocellular carcinoma cells induces apoptosis in T-lymphocytes.
Faisal W; Symonds P; Panjwani S; Heng Y; Murray JC
Asian J Surg; 2007 Jan; 30(1):13-22. PubMed ID: 17337366
[TBL] [Abstract][Full Text] [Related]
4. EMAP-II-dependent lymphocyte killing is associated with hypoxia in colorectal cancer.
Youssef MM; Symonds P; Ellis IO; Murray JC
Br J Cancer; 2006 Sep; 95(6):735-43. PubMed ID: 16929248
[TBL] [Abstract][Full Text] [Related]
5. Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells.
Schwarz MA; Kandel J; Brett J; Li J; Hayward J; Schwarz RE; Chappey O; Wautier JL; Chabot J; Lo Gerfo P; Stern D
J Exp Med; 1999 Aug; 190(3):341-54. PubMed ID: 10430623
[TBL] [Abstract][Full Text] [Related]
6. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.
Berger AC; Alexander HR; Tang G; Wu PS; Hewitt SM; Turner E; Kruger E; Figg WD; Grove A; Kohn E; Stern D; Libutti SK
Microvasc Res; 2000 Jul; 60(1):70-80. PubMed ID: 10873516
[TBL] [Abstract][Full Text] [Related]
7. Pro-EMAP II is not primarily cleaved by caspase-3 and -7.
Zhang FR; Schwarz MA
Am J Physiol Lung Cell Mol Physiol; 2002 Jun; 282(6):L1239-44. PubMed ID: 12003779
[TBL] [Abstract][Full Text] [Related]
8. Synergistic damage of tumor vessels with ultra low-dose endothelial-monocyte activating polypeptide-II and neovasculature-targeted tumor necrosis factor-alpha.
Crippa L; Gasparri A; Sacchi A; Ferrero E; Curnis F; Corti A
Cancer Res; 2008 Feb; 68(4):1154-61. PubMed ID: 18281491
[TBL] [Abstract][Full Text] [Related]
9. EMAP-II facilitates TNF-R1 apoptotic signalling in endothelial cells and induces TRADD mobilization.
van Horssen R; Rens JA; Schipper D; Eggermont AM; ten Hagen TL
Apoptosis; 2006 Dec; 11(12):2137-45. PubMed ID: 17051333
[TBL] [Abstract][Full Text] [Related]
10. Kisspeptin effect on endothelial monocyte activating polypeptide II (EMAP-II)-associated lymphocyte cell death and metastases in colorectal cancer patients.
Stathaki M; Armakolas A; Dimakakos A; Kaklamanis L; Vlachos I; Konstantoulakis MM; Zografos G; Koutsilieris M
Mol Med; 2014 Mar; 20(1):80-92. PubMed ID: 24395571
[TBL] [Abstract][Full Text] [Related]
11. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
Gnant MF; Berger AC; Huang J; Puhlmann M; Wu PC; Merino MJ; Bartlett DL; Alexander HR; Libutti SK
Cancer Res; 1999 Sep; 59(18):4668-74. PubMed ID: 10493523
[TBL] [Abstract][Full Text] [Related]
12. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
Liu J; Liu L; Xue Y; Meng F; Li S; Wang P; Liu Y
Biochem Pharmacol; 2014 Jun; 89(4):477-89. PubMed ID: 24792437
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II).
Berger AC; Alexander HR; Wu PC; Tang G; Gnant MF; Mixon A; Turner ES; Libutti SK
Cytokine; 2000 Jul; 12(7):992-1000. PubMed ID: 10880244
[TBL] [Abstract][Full Text] [Related]
14. Endothelial monocyte activating polypeptide II (EMAP II) enhances the effect of TNF on tumor-associated vasculature.
Kayton ML; Libutti SK
Curr Opin Investig Drugs; 2001 Jan; 2(1):136-8. PubMed ID: 11527006
[TBL] [Abstract][Full Text] [Related]
15. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ΞΆ/PP2A-dependent signaling mechanism.
Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB
Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443
[TBL] [Abstract][Full Text] [Related]
16. Endothelial monocyte-activating polypeptide-II and its functions in (patho)physiological processes.
van Horssen R; Eggermont AM; ten Hagen TL
Cytokine Growth Factor Rev; 2006 Oct; 17(5):339-48. PubMed ID: 16945568
[TBL] [Abstract][Full Text] [Related]
17. Prostate adenocarcinoma cells release the novel proinflammatory polypeptide EMAP-II in response to stress.
Barnett G; Jakobsen AM; Tas M; Rice K; Carmichael J; Murray JC
Cancer Res; 2000 Jun; 60(11):2850-7. PubMed ID: 10850427
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced EMAP-II transcription in colorectal cancer.
Youssef MM; Heng YM; Powe DG; Edgson J; Ellis IO; Murray C
Egypt J Immunol; 2010; 17(2):121-9. PubMed ID: 23082492
[TBL] [Abstract][Full Text] [Related]
19. Endothelial-monocyte activating polypeptide II disrupts alveolar epithelial type II to type I cell transdifferentiation.
Chen Y; Legan SK; Mahan A; Thornton J; Xu H; Schwarz MA
Respir Res; 2012 Jan; 13(1):1. PubMed ID: 22214516
[TBL] [Abstract][Full Text] [Related]
20. Expression of endothelial monocyte-activating polypeptide II in the rat dental follicle and its potential role in tooth eruption.
Liu D; Wise GE
Eur J Oral Sci; 2008 Aug; 116(4):334-40. PubMed ID: 18705801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]